Submit the keyword or topic you are searching for

  1. Home
  2. Top
  3. CAR T in CLL: Data Highlights and Long-Term Outcomes From ASH 2024
Top

CAR T in CLL: Data Highlights and Long-Term Outcomes From ASH 2024

featured-image

Experts discuss recent data updates from the TRANSCEND CLL-004 study on the combination of lisocabtagene maraleucel (liso-cel) and ibrutinib, the potential curative role of chimeric antigen receptor T-cell therapy (CAR T) in relapsed/refractory chronic lymphocytic leukemia (R/R CLL), and the future outlook for CAR T in treating R/R CLL.

Video content above is prompted by the following:.

My Protein Germany

Myprotein UK

Menkind UK

Top News

FCT People Are Happy With Tinubu – Wike

The Minister of Federal Capital Territory (FCT), Nyesom Wike...

'Babar Azam needs one good innings to bounce back'

Bengaluru metro records highest-ever daily ridership despite recent fare hike

Celebrity Big Brother viewers left ‘disgusted’ at ‘attention-seeking’ Jojo Siwa and Chris Hughes

Related Posts

post-thumbnail
Top

FCT People Are Happy With Tinubu – Wike

post-thumbnail
Top

'Babar Azam needs one good innings to bounce back'

post-thumbnail
Top

Bengaluru metro records highest-ever daily ridership despite recent fare hike

post-thumbnail
Top

Celebrity Big Brother viewers left ‘disgusted’ at ‘attention-seeking’ Jojo Siwa and Chris Hughes

post-thumbnail
Top

Brit, 27, dies in horror avalanche at French ski resort

post-thumbnail
Top

France says allowing humanitarian aid into Gaza is 'obligation'

post-thumbnail
Top

Kenneth Choi and the '9-1-1' cast react to Peter Krause's abrupt departure: 'It Was Devastating to Me'

post-thumbnail
Top

Why Pakistan’s ruling elites keep harping on two-nation theory